Founders Financial Alliance’s CONMED CNMD Stock Holding History

Founders Financial Alliance’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-37	Closed	-$3K	–	586
2020 Q3	$3K	Buy	+37	New	+$3.02K	﹤0.01%	1125

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Founders Financial Alliance's CNMD Position: Q4 2020 in Review

Founders Financial Alliance sold out of CONMED (CNMD) in Q4 2020, closing a stake of 37 shares — an estimated $3K sold.

Founders Financial Alliance first reported a position in CNMD in Q3 2020 and held it in 1 quarter. The position peaked at $3K in Q3 2020. 249 funds tracked by Wall St. Rank hold CNMD as of Q4 2020.

Founders Financial Alliance reported no remaining CONMED position as of Q4 2020 after selling out during the quarter.
Founders Financial Alliance sold 37 CONMED shares in Q4 2020, an estimated $3K.
Founders Financial Alliance first reported a position in CONMED in Q3 2020 and held it in 1 quarter.
Founders Financial Alliance's CONMED position peaked at $3K in Q3 2020.
249 funds tracked by Wall St. Rank held CONMED as of Q4 2020.

Based on Founders Financial Alliance's 13F filing for Q4 2020, filed 4 Feb 2021.